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Abstract
Background: Chronic diseases have emerged as a serious threat for health, as well as for global development. They
endenger considerably increased health care costs and diminish the productivity of the adult population group
and, therefore, create a burden on health, as well as on the global economy. As the management of chronic
diseases involves long-term care, often lifelong patient adherence is the key for better health outcomes. We carried
out a systematic literature review on the impact of mobile health interventions -mobile phone texts and/or voice
messages- in high, middle and low income countries to ascertain the impact on patients’ adherence to medical
advice, as well as the impact on health outcomes in cases of chronic diseases.
Methods: The review identified fourteen related studies following the defined inclusion and exclusion criteria, in
PubMed, Cochrane Library, the Library of Congress, and Web Sciences. All the interventions were critically analysed
according to the study design, sample size, duration, tools used, and the statistical methods used for analysing the
primary data. Impacts of the different interventions on outcomes of interest were also analysed.
Results: The findings showed evidence of improved adherence, as well as health outcomes in disease
management, using mobile Short Message Systems and/or Voice Calls. Significant improvement has been found on
adherence with taking medicine, following diet and physical activity advice, as well as improvement in clinical
parameters like HbA1c, blood glucose, blood cholesterol and control of blood pressure and asthma.
Conclusions : Though studies showed positive impacts on adherence and health outcomes, three caveats should
be considered, (i) there was no clear understanding of the processes through which interventions worked; (ii) none
of the studies showed cost data for the m-health interventions and (iii) only short term impacts were captured, it
remains unclear whether the effects are sustained. More research is needed in these three areas before drawing
concrete conclusions and making suggestions to policy makers for further decision and implementation.
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Background
Chronic diseases, both communicable (CD) and non-
communicable (NCD), have emerged as serious challenges
for health, as well as global development. They have sub-
stantially increased health care costs, limited productivity,
especially in low and middle income countries (LMICs),
and added to the existing burden of poverty on countries’
economy. Among chronic communicable diseases (CDs),
HIV/AIDS is the most common cause of morbidity and
mortality worldwide. According to World Health
Organization (WHO), approximately 35.0 million people
were living with HIV at the end of 2013, with 2.1 million
people globally becoming newly infected in 2013. The bur-
den of the epidemic varies considerably between countries
and regions, with the majority, 2.9 million, being in low-
and middle income countries [2]. Sub-Saharan Africa is
the most affected region, with 24.7 million people living
with HIV in 2013, and accounting for almost 70 % of the
global total of new HIV infections [29, 40].
In 2010, the WHO Global Status Report on NCDs
showed that NCDs are the biggest cause of death world-
wide. NCDs are estimated to contribute almost 36 million
(80 %) global annual deaths, of which 29 million occur in
LMICs. NCD deaths are projected to increase by 15 % glo-
bally between 2010 and 2020 (44 million deaths). The
greatest increases, by 20 %, will be in Africa, the Eastern
Mediterranean and South East Asia. WHO does not esti-
mate an increase in the European Region. Lack of accessi-
bility, inequality and inequity in health service provision
are the main barriers to provide services for chronic dis-
ease care, mainly in LMICs. Follow-up is mostly sporadic,
while adherence to treatment, life style changes, and self
management is overlooked, community services are ig-
nored, prevention is not emphasized and referral linkage
is not well established and/or not functional [28].
In 2013, global mobile phone penetration rates stood at
96 % worldwide (Information and Communication Tech-
nology ICT facts and figures, [18]). Use of mobile technolo-
gies in health, as well as advancement in innovative
applications to address health priorities, has evolved into a
new field of e-health known as m-Health (mobile health).
E-health is a term for health care practices supported by
electronic/ digital processes and also refers to health care
practices using the internet. m-Health is a new field of e-
health which involves the use of mobile phone core func-
tions including voice and short messaging services (SMS),
as well as more complex functions and specialized applica-
tions. For example, bluetooth technology could be linked
with health parameter devices (e.g., glucometer) [29]. Inter-
ventions may also include a phone platform where patients
can call, in case they have questions or emergency. The
growing mobile phone networks, with increased accessibil-
ity providing the opportunity for more personalized and
citizen-centered medical care, have been found to lower the
health system barriers, particularly patient access, as well as
reduce the health care service cost [19]. m-health is now
being used as a tool to achieve a number of other objec-
tives: accessing people irrespective of socio-economic status
(SES), increasing patients’ satisfaction with quality health
care and improving adherence, which, in the end, benefits
patients, providers, and health care systems. However, mo-
bile health care interventions are still new and, to the best
of our knowledge, no systematic review has yet been pub-
lished that analyses evidence on whether the use of mobile
phone interventions (SMS or voice message and/or inter-
active call and emergency call) improves patient adherence
or the process of care and health outcomes, without linkage
to any other web-based interventions (e-mail, skype etc.).
In the context of LMICs with low internet penetration and
low smartphone penetration, as well as low literacy rate
and individual SES (socio-economic status) it is important
to use mobile applications independently of internet access
to be able to reach all types of individuals [15, 27].
Therefore, the aim of this review is to gather scientific
evidence on the effective uses of mobile phones through
SMS and/or voice messages, with or without emergency
phone calls and/or interactive calls, to see the effect on
patients’ adherence and clinical outcomes, with the ob-
jective of advising policy makers on the use and effective
implementation of m-Health technologies.
Methods
Data sources
PubMed, Cochrane Library, the Library of Congress, and
Web Sciences were searched for related articles. The key-
words used for the search were – “m-Health”, “mobile
communication”, “telemedicine technologies”, “interven-
tions”, “adherence”, “compliance”, “chronic diseases”, “chro
nic conditions”, “randomized control trial”, “clinical trial”,
“experimental design”, “quasi-experimental design”, and
“observational study”. The same keywords have been used
for all search engines.
Inclusion and exclusion criteria
The eligibility criteria for study inclusion were (1) pa-
tients with chronic diseases (both communicable and
non-communicable) living in high, middle or low in-
come countries, (2) mobile health intervention, (3) ex-
perimental, quasi- experimental, and observational
studies, (4) publications in peer-reviewed journals, and
(5) publications written in English. Exclusion criteria
were (1) studies focusing on non chronic diseases (2)
studies in which a mobile phone was used together with
other web based interventions, (3) reviews, policy pa-
pers, feasibility studies, grey publications, reports, book
chapters, and master/bachelor theses, (4) publications
not written in English and (5) publications in non peer-
reviewed journals.
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Data extraction
Two of the authors (FY and BB) independently searched
for articles using the same search engines and the same
key words list. After the initial individual search, 236 po-
tential articles were identified (FY 164, BB 99, among
them 27 articles were common to both reviewers). We
considered all papers published up to May 2014 when
the review has been done. The first author (FY) has then
reviewed all the titles and abstracts to decide whether
the full text should be examined. 66 grey and policy
papers, 23 systematic reviews or meta-analysis and 11
articles focusing on non-chronic conditions or diseases
were excluded. After the primary exclusion, 136 full texts
were screened. Finally, 122 articles which includes add-
itional interventions, like web based interventions, together
with mobile phone SMS and voice call interventions, were
excluded. At the end, 14 articles met the full inclusion cri-
teria. (Fig. 1).
Data analysis
The reviewed articles were categorized according to clin-
ical areas (Diabetes, HIV/Anti-Retro Viral Therapy,
Asthma and Hypertension) and analysed according to
the study design, sample size, intervention (process and
duration), methodological traits, tool/s used as well as
the frequency of use, measurement of outcome, and
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Fig. 1 Review process of the articles. Two of the authors independently searched for articles using the same search engines (PubMed, Cochrane
Library, the Library of Congress, and Web Sciences) and the same key words (“m-Health”, “mobile communication”, “telemedicine technologies”,
“interventions”, “adherence”, “compliance”, “chronic diseases”, “chronic conditions”, “randomized control trial”, “clinical trial”, “experimental design”,
“quasi-experimental design”, and “observational study”). All papers published up to May 2014 were considered when the review has been done.
All the titles and abstracts has been screened to decide whether should be included in the review paper following the inclusion and exclusion
criteria; grey and policy papers, systematic reviews or meta-analysis and articles focusing on non-chronic conditions or diseases were excluded.
The articles which includes additional interventions, like web based interventions, together with mobile phone SMS and voice call interventions,
were also excluded. Finally, 14 articles met the full inclusion criteria and incorporated in the paper
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research location. The researchers carefully checked for
the tools used for measuring adherence, both at baseline
and end-line of the intervention, for both control and
intervention groups. The results of the interventions
were analysed according to the clinical areas, as well
as across the clinical areas and extracted into a matrix
(Tables 1, 2 and 3). The review has been done following
the PRISMA.
Results
From a total of 236 potential reseach results, 136 full texts
were selected for review, of which 14 articles were included,
following the inclusion criteria. These studies include 12
randomized-controlled trials, 1 quasi-experimental cohort,
and 1 cross-sectional and descriptive study.
Characteristics of reviewed studies
Health content area
Seven studies focused on HIV/AIDS and anti-retro viral
therapy [8, 17, 24–26, 32, 33], four studies focused on
diabetes management [13, 16, 34, 38], two studies exam-
ined asthma management [31, 35], and one assessed
hypertension [5].
All articles focused both on secondary prevention
(educate people to slow down the process of disease
after being diagnosed through regular health check-up,
follow physician advice regarding drug, diet, life style
changes etc.) and tertiary prevention (slow down the de-
velopment process of disease complications).
Study design and sample
Out of the fourteen studies, twelve studies employed an
experimental design involving intervention and non-
intervention groups [5, 8, 13, 16, 17, 25, 26, 31, 32, 34,
35, 38], one was a quasi-experimental cohort study [33],
and one a cross sectional and descriptive study [24].
Regarding sample size, five studies had sample sizes
below 100 [5, 8, 13, 16, 35] and out of these, two studies
had a sample size of less than 25 [8, 35].
Regarding the age of participants, thirteen studies in-
volved adults (18 years or above), and only one study fo-
cused solely on children/teenagers, e.g. 8–18 years [13].
Technology and mode of intervention
Out of fourteen studies, ten studies used only SMS, ei-
ther short and/or long form, as an intervention. Three
studies used SMS together with another intervention:
one with an emergency hotline [13], one with voice call
[24] and the last one used picture SMS together with an
interactive voice response IVR (voice call) [33]. One
study used only voice call without use of any SMS [17].
The frequency of message delivery, or voice call, dif-
fers from study to study. In two studies, SMS were deliv-
ered daily [13, 35], in three studies, SMS were delivered
weekly [25, 26, 33], one study was a combination of a
short SMS delivered daily and a long SMS weekly [32],
in one, SMS were delivered every 3 days [34], in one, 2
SMS were delivered weekly [5], in one, 4 SMS were de-
livered weekly [16], and in one, 1 SMS was delivered
every 4 weeks [24]. Three studies had a different system:
one delivered 2 SMS weekly for the first 1-6 weeks and
daily SMS for the next 7-12 weeks and 3 SMS weekly
for the remaining 13-18 weeks [31]; one delivered SMS
on Saturday and Sunday and every alternating working
day -30 min before the last scheduled time of medicine
intake [8] and one delivered SMS only if the patient
didn’t open the medication dispenser [38]. In one study,
patients were contacted only through a voice call once
in every 2 weeks [17].
For all studies, SMS were sent in local languages or
patients’ preferred languages for better access and
understanding.
The duration of these studies ranged from 3 to
12 months. Six studies lasted from 3-4 months [5, 8, 16,
17, 31, 35], four lasted between 6-7 months [24, 26, 33,
38] and four studies lasted for 12 months [13, 25, 32, 34].
Content of the tools (message or voice call)
The content of the message varied in each intervention.
Mostly, the messages consisted of simple reminders to
take medicine, follow physician’s advice on diet or other
life style changes activities and attend clinic/hospital
on time, but a few messages were customized according
to the patients’ clinical needs. Vervloet et al. [38],
Pop-Eleches et al. [32], da Costa et al. [8], Strandbygaard
et al. [35], and Mbuagbaw et al. [26] discussed about
very precise SMS reminders of only taking pills. Shetty
et al. [34], Goodarzi et al. [16], Petrie et al. [31] and
Contreras et al. [5] reported messages comprised of var-
ied instructions on medical nutrition therapy, physical
activity, reminders on drug prescription and clinical
visits, and healthy living habits. But not all messages
were passively received, some messages provided infor-
mation/prompts and required interaction from the pa-
tients. In Lester et al. [25] survey patients had to
respond to the message and the clinician called back if
the patient had any problem, or failed to respond to the
SMS within 48 h. In Rodrigues et al. [33], patients had to
answer a question about whether they had taken medi-
cines. In some studies, patients were contacted by inter-
active voice calls. Kunutsor et al. [24] reported contacting
the patients by voice calls or SMS in case of missed clinical
appointment, as a reminder, and reasons for missed ap-
pointments were also recorded. Huang et al. [17] showed
that patients were getting calls for attending scheduled
visits and were welcome to ask questions concerning treat-
ment and other health related issues. Mbuagbaw et al. [26]
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Table 1 Key findings in the clinical area of Diabetes Mellitus Type I and II
Lead
Author/Year
Country Study
design
Sample
size
Duration Age group
(in Years)
Intervention Delivery frequency Measures of outcome Results – control (C)
versus intervention (I)
Ananth
Samoth
Shetty/2011
[34]
India RCT 215 12 months 30–65 SMS Once in 3 days Adherence to management
prescription
Hb1Ac level
I: 30.8 to 55.1 %
C: 31.8 % to 48.5 %.
V. L.
Franklin/
2006 [13]
Scotland RCT 90 12 months 8–18 SMS,
emergency
hotline
Daily SMS Self-efficacy, adherence to treatment I and C using conventional therapy:10.3 ± 1.7
vs. 10.1 ± 1.7 %
I with intensive insulin therapy and Sweet Talk:
9.2 ± 2.2 %, 95 % CI −1.9, −0.5, P < 0.001
Self-reported adherence: conventional therapy
70.4 ± 20.0, conventional therapy plus Sweet Talk
77.2 ± 16.1, 95 % CI +0.4, +17.4, P = 0.042
M. Vervloet/
2012 [38]
Netherland RCT 104 6 months 18–65 SMS
reminder
SMS only incase
patient didn’t open
the medication
dispenser
Adherence to oral hypoglycaemic
agent
Doses within predefined time windows, within a
1-h window
I: 50 %
C:39 %
within a 4-h window
I: 81 %
C: 70 %
Mandana
Goodarzi/
2012 [16]
Iran RCT 81 3 months 30+ SMS 4 SMS weekly Improving laboratory test levels and
Knowledge, Attitude, Practice (KAP)
and Self Efficacy (SE) of patients
HbA1C level
C: 7.83 to 7.48 %
I: 7.91 to 7.02 %.
LDL level
C: 99.13 mg/dl to 98.95 mg/dl
I: 97.88gm/dl to 87.93gm/dl.
Triglyceride
C: 173.4 mg/dl to 169.08 mg/dl
I: 179.72 gm/dl to 160.16gm/dl.
Knowledge improved 7.97 to 10.83 %, practice
3.72 to 4.93 %, and SE 15.34 to 17.02 % in I I
group.
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Table 2 Key findings in the clinical area of HIV/AIDS (Anti-retro Viral Therapy)
Lead Author/Year Country Study design Sample
size
Duration Age
group
Intervention Delivery
frequency
Measures of outcome Results Control (C) versus Intervention
(I)
Cristian Pop-Eleches/
2011 [32]
Kenya RCT 428 12 months 18+ SMS- Short and long Short- daily,
Long- weekly
Adherence to ART Adherence of at least 90 % during
48 weeks of study in
I: 53 %
C: 40 %
Richard T Lester
/2010 [25]
Kenya RCT 538 12 months 18+ SMS Weekly Drug adherence,
suppression of
plasma viral load
Adherence to ART
I: 61.5 %; C: 49.81 %. Suppressed plasma
viral loads I: 60.4; C: 48.3 %.
Rashmi Rodrigues
/2012 [33]
India Quasi-experimental
cohort
150 6 months 18+ Interactive voice call
and picture message
Weekly Adherence, Pill count Adherence at baseline, month 1, month
3, month 6, month 9 and month 12
were 85 %, 94 %, 93 %, 91 %, 95 %,
and 94 % respectively.
Setor Kunutsor/2010
[24]
Uganda Cross-sectional and
descriptive
176 7 months 18+ Voice call and SMS 4 weekly Attendance. Drug refill Mean adherence before and after
intervention was 96.3 % and 98.4 %
respectively ((95 % confidence interval).
Dongsheng Huang
/2013 [17]
China RCT 172 3 months 18+ Voice call 2 weekly Adherence to ART
and quality of life (QOL)
CD4 count:
Baseline: Treatment naïve group
I: 191/mm3; C: 216/ mm3
Treatment experienced
I: 286/mm3; C: 348/ mm3.
End line: Treatment naïve group
I: 308/mm3; C: 298/ mm3.
Treatment experienced group-
I: 324/mm3; C: 356/ mm3.
Adherence rate: I: above 98 %, C:
fluctuated slightly
Thiago Martini da
Costa/2012 [8]
Brazil RCT 21 4 months 18+ SMS Every alternative
working day + Sat.
+ Sun. day
Self-reported adherence,
pill count
Self-reported adherence
I: remained 100 % in I group, C: 100 to
92.31 %
Pill count
I: 75.00 to 62.50 %.
C: 69.23 to 46.15 %.
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Table 2 Key findings in the clinical area of HIV/AIDS (Anti-retro Viral Therapy) (Continued)
Lawrence
Mbuagbaw/2012 [26]
Cameroon RCT 200 6 months 21+ SMS Weekly Visual Analogue Scale,
number of doses missed
(in the week preceding
interview), drug refill
No significant effect on adherence by
VAS > 95 %
(risk ratio1.06, 95 % CI 0.89, 1.29;
p = 0.542; reported missed doses
(RR 1.01, 95 % CI 0.87, 1.16; p.0.999) or
number of pharmacy refills (mean
difference 0.1, 95 %
CI: 0.23, 0.43; p = 0.617.
CD4 count at end of 3 months:
C: 327/mm3 to 375/mm3
I: 347/mm3 to 406/mm3.
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Table 3 Key findings in the clinical area of Asthma and Hypertension
Lead Author/Year Country Study
design
Sample
size
Duration Age
group
Clinical
area
Intervention Delivery frequency Measures of outcome Results Control (C) versus
intervention (I)
Ulla Strandbygaard/
2010 [35]
Denmark RCT 22 3 months 18–45 Asthma SMS Daily Adherence to asthma treatment,
lung function tests
Mean adherence rate
I: 77.9 to 81.5 %;
C: 84.2 to 70.1 %.
Keith J. Petrie/
2011 [31]
New
Zealand
RCT 147 4.5 months 16–45 Asthma SMS 2 SMS/day for first
1–6 weeks, 1 SMS/day
for next 7 – 12 weeks,
and 3 SMS/ week for
rest 13 – 18 weeks
Self-reported adherence,
adherence to treatment
Self-reported adherence over all time
points
C: 43.2 %
I: 57.8 %
Percentage taking over 80 % of
prescribed inhaler doses
C: 23.9 %
I: 37.7 %
E. Márquez
Contreras/2004 [5]
Spain RCT 67 6 months 18+ HTN SMS 2 SMS / week Adherence to drug, blood pressure
measurement
Mean percentage adherence
I: 91.1 ± 23.1 to 95.0 ± 10.4
C: 86.2 ± 26.6 to 86.1 ± 23.4
% of controlled hypertension at end
of study-
C: 51.5 %; I: 64.7 %.
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reported adding a contact phone number with the SMS,
on which patients could call in case of emergency or any
other concern.
Publication source
The studies about HIV/AIDS, diabetes and asthma were
mainly published in the journals focusing on these spe-
cific clinical areas, while the others were published in
more broadly themed journals. One article was pub-
lished in an international medical informatics journal.
Location of research
According to the World Bank list of economics, five
studies were conducted in high income countries
(Denmark, Netherlands, New Zealand, Scotland, Spain),
two in upper middle income countries (Brazil, Iran), four
in lower middle income countries (China, Cameroon,
two in India) and three studies in low income countries
(two in Kenya, Uganda) [39].
Studies measured adherence and outcome of care
Out of fourteen studies, seven studies reported only on
adherence to treatment, one study focused on the clinical
outcome, five studies reported to both adherence and clin-
ical outcome and one study reported on clinical outcome
together with knowledge, practice, attitude and self efficacy.
Adherence to treatment and health care behaviour
In the reviewed articles, the main concept of measuring
adherence was taking medicine according to physician's
advice. One study also used the concept of self efficacy,
knowledge, attitude, practice and QoL. The tools used for
measuring adherence were drug refill, pill count, and self
report.
HIV/AIDS
Pop-Eleches et al. [32] reported that 53 % of the inter-
vention group patients achieved adherence of at least
90 % during the intervention period of the study, com-
pared to 40 % of participants in the control group (p =
0.03). Lester et al. [25] showed that adherence to ART
was reported by 61.5 % in the intervention group com-
pared to 49.81 % in the control group (relative risk for
non-adherence 0 · 81, 95 % CI 0 · 69–0 · 94; p = 0 · 006).
Self-reported adherence remained significantly better in
the intervention group than the control group (odds
ratio 0 · 57, 95 % CI 0 · 40–0 · 83; p = 0 · 0028). According
to Rodrigues et al. [33] adherence increased from 85 to
94 % after 12 months of intervention, using both inter-
active voice call and picture message. Kunutsor et al.
[24] reported mean adherence (95 % CI) 96.3 % and
98.4 %, before and after mobile phone intervention
(voice call and SMS) respectively. According to Huang
et al. [17], follow up rate increased from 91.3 to 95.7 %
in the intervention group, whereas it showed a decreasing
trend from 97.9 to 93.6 % in the non-intervention group.
da Costa et al. [8] also showed that self-reported adherence
remained at 100.00 % in the intervention group and de-
creased from 100.00 % to 92.31 % in the control group. In
contrast, the pill counting method showed a decrease in
both groups from the baseline to end-line, but decreased
more in the control group in comparison to the interven-
tion group (control group: from 69.23 to 46.15 % and inter-
vention group: from 75.00 to 62.50 %). Mbuagbaw et al.
[26] showed no significant effect on adherence (>95 %, risk
ratio 1.06, 95 % confidence interval; p = 0.542) in the inter-
vention group by VAS (Visual Analogue Scale is a psycho-
metric response scale which is used in questionnaires as a
measurement instrument for subjective characteristics or
attitudes that cannot be measured directly) or self-reported
missed doses (RR 1.01, 95 % CI 0.87, 1.16; p.0.999) at the
end of the 6 month intervention. The mean number of
pharmacy refills was also not different between groups
(mean difference 0.1 95 % CI - 0.23, 0.43; p = 0.617).
Diabetes
According to Shetty et al. [34], adherence to dietary pre-
scriptions decreased in both groups (control group: 54.5
to 52 %, intervention group: 60.3 to 58.4 %). In the same
study, adherence to the physical activity advice in the con-
trol group were 47% and 52 % at the baseline and end-
line, respectively. In the intervention group, the adherence
improved marginally from 47 to 56 %, which was not sta-
tistically significant. Franklin et al. [13] showed an im-
proved self-reported adherence score (Conventional
Insulin Therapy alone 70.4 ± 20.0, CIT with SMS 77.2 ±
16.1, 95 % CI +0.4, +17.4, P = 0.042). Vervloet et al. [38]
reported that patients who received SMS reminders took
significantly more doses within predefined windows of
time than patients receiving no reminders: 50 % vs. 39 %
within a 1-h window (p = 0.003) up to 81 % vs. 70 %
within a 4-h window (p = 0.007). Reminded patients
tended to miss doses less frequently than patients not
reminded (15 % vs. 19 %, p = 0.065), but days without dos-
ing were not significantly different between groups. Good-
arzi et al. [16] showed that knowledge improved from 7.97
to 10.83 %, practice from 3.72 to 4.93 %, and self-efficacy
(SE) from 15.34 to 17.02 % in the intervention group,
whereas there was no significant improvement found in
the control group (knowledge: from 8.05 to 8.68 %,
practice: from 3.86 to 4.26 %, SE: from 15.86 to 15.31 %)
according to the KAP survey.
Asthma
According to Strandbygaard et al. [35], the absolute dif-
ference in mean adherence rate between control and
intervention groups was 17.8 %, [95 % CI (3.2 - 32.3 %),
p = 0.019]. Similarly, Petrie et al. [31] showed a
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significant improvement in adherence over the follow-up
period in the intervention group, compared to the con-
trol group, with a relative average increase in adherence
of 10 % (p < .001). The percentage of taking over 80 % of
prescribed inhaler doses was 23.9 % in the control group
compared to 37.7 % in the intervention group (p < .05).
Hypertension
According to Contreras et al. [5] the mean (±SD) adher-
ence in the intervention group was 91.1 ± 23.1, 91.5 ±
12.0 and 95.0 ± 10.4 at 1st, 3rd and 6th months, respect-
ively, whereas in the control group it was 86.2 ± 26.6,
87.6 ± 20.1, and 86.1 ± 23.4 (p =NS).
Clinical improvement
Seven out of fourteen studies reported significant changes
in the clinical outcomes as a result of voice call or SMS be-
ing sent through a mobile phone [5, 13, 16, 17, 25, 31, 34].
The remaining seven studies only measured adherence
and did not look at the clinical outcomes.
HIV/AIDS
Out of seven studies focused on antiretroviral therapy,
only three [17, 25, 26] measured clinical outcomes at
the end of the intervention, either as a primary
outcome or as a secondary outcome measure of
adherence.
According to Lester et al. [25], plasma viral loads were
reported 60.4 % in the intervention group and 48.3 % in
the control group at end-line, but the intention-to-treat
analysis showed weak evidence of improved suppression
of viral load in the SMS group compared with the con-
trol group (OR 0.71, 95 % CI 0.50–1.01; p = 0.058).
Huang et al. [17] reported significant improvement in
clinical outcomes (CD4 count) in the intervention group
from 286/mm3 to 324/mm3, whereas in the control
group they reported an increase from 348/ mm3 to 356/
mm3 within the patient group who already experienced
anti-retro viral treatment. They also showed an in-
creased CD4 count in the intervention group, from 191/
mm3 to 308/ mm3, with the treatment-naïve group pa-
tients after 3 months of intervention and 216/ mm3 to
298/ mm3 in the control group. In contrast to the above
reports, Huang et al. [17], showed no statistically signifi-
cant difference in mean CD4 count, weight change,
WHO clinical staging, and opportunistic infections be-
tween the intervention and control groups among both
treatment-naïve and treatment-experienced patients.
Among treatment-naïve patients, mean QoL scores at
baseline among the intervention and the control groups
were the same. However, the scores after 3 months were
significantly higher among patients who received a mo-
bile call intervention in the area of physical well-being,
level of independence, environment, and spiritual/
religious/personal believes. Mbuagbaw et al. [26] showed
an evidence of improved CD4 count at the end of
3 months from 347/mm3 to 406/mm3 in the interven-
tion group and 327/mm3 to 375/mm3 in the control
group. But no data was reported on the CD4 count at
the end of the intervention of 6 months.
Diabetes
Three studies reported on clinical outcome; 2 on type 2
[13, 16] and one on type 1 Diabetes [34].
Shetty et al. [34] reported significant improvement in
the mean Fasting Plasma Glucose (FPG) level (185 +
57 mg/dl to 166+ 54, p < 0.002) and 2 h (PG 263 + 84 mg/
dl to 220 + 67, p <0.002) in the intervention group at the
end of one year of intervention. No significant difference
in the mean HbA1C value was found in any of the groups.
Serum TC (Total Cholesterol) decreased significantly in
both groups (Control: 175+ 47 mg/dl to 164+ 38 mg/dl,
p < 0.03 and intervention: 179+ 42 mg/dl to 164+ 31 mg/
dl, p < 0.03). According to Franklin et al. [13], there was
no change in HbA1c levels in patients on conventional
therapy with or without voice call (10.3 ± 1.7 vs. 10.1 ±
1.7 %), but it improved in patients randomized to inten-
sive insulin therapy plus voice call (9.2 ± 2.2 %, 95 % CI
−1.9, −0.5, p < 0.001). The study also reported no change
in mean glycaemic control in patients with Conventional
Insulin Therapy (CIT alone 10.3 ± 1.7 %, CIT plus Sweet
Talk 10.1 ± 1.7 %), but it improved in patients allocated to
intensive insulin therapy plus Sweet Talk (9.2 ± 2.2 %,
95 % CI -1.9, - 0.5, p < 0.001). Goodarzi et al. [16] showed
that Hb1Ac levels improved significantly in the interven-
tion group after 3 months of intervention (from 7.91 to
7.02 %); however it also showed improvement in the non-
intervention group (from 7.83 to 7.48 %). The study also
reported significant improvement in other clinical out-
comes: LDL (Low- density Lipoprotein) from 97.88 mg/dl
to 87.93 mg/dl, Triglyceride from 179.72 mg/dl to
160.16 mg/dl, and Total Cholesterol from 180.88 mg/dl to
165.95 mg/dl.
Asthma
Strandbygaard et al. [35] reported clinical outcomes for
Asthma. They showed overall improvement in Exhaled Ni-
tric Oxide (p < 0.001), Airway Responsiveness (p < 0.001)
and Forced Expiratory Volume (FEV1) (p = 0.015), though
the changes in these parameters were not significantly dif-
ferent in any of the groups.
Hypertension
Contreras, et al. [5] reported a significantly higher pro-
portion of control of hypertension among the patients in
the intervention group, (64.7 % CI, 48.6 % to 80.8 %)
compared to control group (51.5 % CI, 34.4 % to
68.6 %). Among the intervention group, mean systolic
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blood pressure at initial level, 1st month, 3rd month and
6th month was 158.5 ± 13.9, 143.6 ± 14.7, 141.8 ± 14.1,
and 139.4 ± 13.1 mm Hg, respectively, whereas in the
control group the corresponding values were 162.1 ±
13.9, 145.7 ± 11.8, 143.8 ± 13.7, and 138.3 ± 9.5 mm Hg
(p = NS). In the same study, the mean diastolic blood
pressure in the intervention group was 95.6 ± 7.9, 86.94
± 9.8, 84.87 ± 10.1, and 84.94 ± 10.4 mm Hg, respectively,
and in the control group was 95.4 ± 6.8, 86.0 ± 7.0, 85.1
± 6.8, and 83.1 ± 5.6 mm Hg, respectively, (p =NS).
Mean decrease in systolic blood pressure in the inter-
vention group was 19.1 ± 14.4 mm Hg and in diastolic
blood pressure, it was 10.6 ± 7.9 mm Hg. On the other
hand, the mean decrease in systolic blood pressure in
the control group was 23.7 ± 13.1 mm Hg and in case of
diastolic blood pressure, it was 12.3 ± 7.5 mm Hg.
Discussion
This review identified 14 health behaviour studies evaluat-
ing the effectiveness of mobile SMS and/or voice SMS or
MMS, individually or in combination with other interven-
tion modalities, such as interactive voice call or emergency
hotline. This review excluded the articles which combined
m-Health intervention with other web based components
such as e-mail, skype, video conferencing, bluetooth and
telecommunication, to find out clear evidence if m-Health
alone could have an impact on the adherence and clinical
outcomes, as mobile technology is more widely accessible
and affordable, especially in LMICs.
There are several limitations identified in systematic re-
view and meta-analysis, like publication bias, heterogenicity
across the primary study, lack of scope of comparability
and language. [1, 10]. Publication bias is a potential threat
for all areas of research, including systematic review. A
comprehensive search of available literature may reduce the
possibility of publication bias, which occurs when studies
showing positive impact of interventions are more likely to
be published and cited [14]. Pre-selection of language is an-
other potential limitation of a review paper. Excluding non-
English studies may change the result of the review, as it
may already exclude some important articles published in
non-English journals. Including only peer reviewed articles
increases the likelihood of missing a chance to access some
important interventions as well. At the same time, the peer
review system enhances the quality of a paper and it can be
assumed that papers not published in the peer review sys-
tem don’t have the same quality. Heterogenicity in the pri-
mary study was also listed as a limitation [41]. In this
systematic review, twelve out of the fourteen studies were
Randomized Control Trials, so the designs were not
heterogenous. Despite that, we observed some differences
in terms of sample size, process of intervention and tools
used, which created some difficulties in drawing a conclu-
sion about the effect of the interventions.
Five studies out of fourteen had a sample size below
hundred [5, 8, 13, 16, 35] and specifically, two studies had
a sample size less than 25 [8, 35] which raises the question
of representativeness of the study population. da Costa
et al. [8] stated that the main reason for not getting the
desired sample size, was that they could not find the
women who possessed mobile phones. Strandbygaard
et al. [35] stated that only 26 patients were eligible for
randomization for the study and, out of them, 22 patients
completed the study. The questions of sample size and
statistical validity of the studies are illustrative of the prob-
lems encountered with these types of interventions.
Recruiting people may be difficult and/or create biase, in
particular for some specific groups: women or rural inhab-
itants or illiterate persons who may not possess a mobile
phone or may not be able to read the messages and take
part in the intervention [4, 7, 21, 22, 42]. There is also a
question of retaining people in the intervention when a
mobile is lost/broken and/or the number changes, as is
common in LMICs. According to Pop-Eleches et al. [32],
69 participants lost their phones and 51 changed phone
numbers during one year course of the study. Though the
process of intervention was well described in most of the
articles reviewed, but the strains and/or barriers to the in-
terventions were not well documented. Most of the articles
did not mention anything about the strains or barriers to
the intervention or patient drop out and/or discontinuity.
Regarding the tools used in the reviewed articles, SMS,
either in short or long form, was used as the main tool in
thirteen out of fourteen interventions. Voice call and emer-
gency hot line were used as a tool in some interventions,
together with SMS. But the risk of bias exists in cases using
only SMS, as it targets a comparatively young and literate
group of people in the intervention, rather than illiterate
and older people [4, 7, 42]. Young and literate people are
more likely to adopt modern technologies than others, and
inclusion criteria in some of the studies were having a mo-
bile phone or being literate and/or able to read SMS. SMS
subscribers were significantly more likely to report intended
or actual behaviour change (91 %) than voice subscribers,
who have a lower literacy rate and/or no access to a per-
sonal mobile phone (voice call 56 %, hotline 66 %). The re-
call rate of last message (comprehension) was almost the
same in SMS subscribers and hotline users (SMS 75 %, hot-
line 76 %), but slightly lower in voice message subscribers
(63 %) [7]. For the management of chronic illness, a study
showed that 98 % of respondents preferred to receive medi-
cation reminders via mobile phones; among those who pre-
ferred reminders, 89 % preferred only voice calls, 9 %
preferred SMS and 2 % had no specific preference. [9]. Ac-
cording to Rodrigues et al. [33], a significantly higher pro-
portion agreed that a voice call was more helpful when
compared to an SMS (34 % preferred only voice call, 11 %
preferred only SMS, 44 % preferred both the voice call and
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SMS, while 11 % had no specific preference). SMS seems to
have a better impact on changing the behaviour, but at the
same time people preferred a voice call. The potentially
higher impact of SMS, may be due to a higher literacy rate
and access to a personal mobile phone in the SMS group,
compare to the voice call group. Age and sex as confound-
ing factors have not been analysed. So, while SMS may be
considered more efficient, easier to implement and cheaper,
the population reached by this type of intervention has to
be carefully considered and impact needs to be analysed.
Regarding the method of communication, most SMS
were passively received, but some SMS included both pas-
sive and active or interactive components; which should
make the intervention stronger and more reliable [25, 33].
The content of the tools used (mainly SMS) varied a
lot from intervention to intervention.
Some SMS were a very simple and basic reminder to
take medicine or make a hospital visit or for other self
health care behavior. For example: “This is your reminder”
[32], “Take good care of your health” [8], which may raise
the question of the quality of the intervention. But some
SMS interventions were customized according to the pa-
tients’ clinical need and literacy level, as well as with de-
tailed behavioural and lifestyle change contents. In this
systematic review, it was not possible to analyse the differ-
ence in the impact of the various content of the messages,
as positive impact was found in almost all interventions. It
may also be possible that, in the final analysis, an incom-
ing message alert is already a reminder and the content
and/or frequency is not that important. But, according to
Tomlinson et al. [36], SMS is more likely to work if it is
personally tailored, and the content are highly relevant.
Tomlinson et al. [36] also stated that a m-Health pro-
ject is more likely to work if the project is followed up,
has been designed for specific context and strong con-
sideration has been given to the frequency of message
delivery and the content of messages. The variability in
tools, together with the content and frequency of use of
the tools, made the comparison difficult. As a conclu-
sion, positive effects on adherence and health outcomes
were found in most of the studies reviewed and were
short-term (3–12 months). Despite the positive results
of the studies, it must be noted that the projects were all
small-scale and success of similar large-scale or longer
effect projects is not guaranteed and still in question.
[3]. Therefore, further research is needed to find out the
impact of the content of the message, frequency of use,
the medium uses for different behavioural interventions
as well as the sustainability of large scale and long term
interventions. Also, the cost benefits of m-Health inter-
ventions, compared to traditional health education, are
still in question, as there is no available evidence so far.
Adherence refers to the act of following the recommen-
dations made by the provider with respect to time, dosage,
and frequency of medicine intake [6, 20]. Patients’ adher-
ence to a recommended drug regime represents the final
step in a pathway from developing symptoms to receiving
curative treatment [23] and the fact that patients are not
taking drugs as recommended, may be more a result that
patient is not having access to affordable treatment and/or
not receiving the precise instructions, rather than patient
related factors of non-adherence [41]. Adherence to any
treatment regimen is mostly inversely proportional to the
duration of treatment and the frequency of dosing. There-
fore, it is more important for chronic diseases to have a
strong follow up mechanism and strategy to improve pa-
tient adherence to the treatment regimen. There was a
wide range of discrepancies in the definition, measure-
ment of adherence, tools used, content and frequency of
tool use, as well as in clinical areas and the country con-
text. A patient may not fully follow the treatment regimen
or advice as prescribed, but still may receive adequate
treatment or follow some of the lifestyle change advice,
which, at the end, may improve clinical outcomes. An
80 % compliance level for medicine intake is not enough
as a measurement, as the form of drug intake may be
more important than the level of compliance. For ex-
ample, missing one complete week antihypertensive drug,
might result in high blood pressure, with the risk of stroke
and heart failure. But the same number of missed doses
over a period of three-months would have no measurable
effect on blood pressure control [30]. Stronger definitions
of adherence in terms of dose, duration and frequency
would contribute considerably in comparing the results of
different studies, which is lacking in this review. Many re-
views suggest that biologic assays are the most accurate
measure of patient adherence, followed by pill counts, with
self-report being the least accurate. However, there is no
single mesure of adherence which can be recognized as the
most reliable and accurate. The main problem in identify-
ing non-compliant patients is the unreliability of many of
the measures used for assessing compliance, as there are
many factors; psychological, social and demographic, drug
and doctor factors, which may influence the adherence at
various levels [11]. Therefore, it is better to combine mea-
sures to calculate adherence and not rely on only one
measure, which may produce bias or an imperfect result.
Irrespective of the differences and questions which
may arise regarding methodology (design, tool, duration)
and country context, eleven out of fourteen studies re-
ported significant improvement on adherence and clin-
ical outcomes in the intervention groups, in comparison
to the control group, at the end of the intervention.
There is evidence in the published articles that m-
Health works, but it is not clear what works and how it
does work. Tomlinson et al. [36] stated that after com-
pletion of many pilot studies, there is almost nothing
about the likely uptake, best strategies for engagement,
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efficacy, or effectiveness of these initiatives or information
about the cost of the interventions. Flay and colleagues [12]
adapted a standards model, published by the Society for
Prevention Research, which was developed to guide policy,
research, and practice and to provide a framework for
sufficient evidence. But there are currently no m-Health
interventions that meet these standards for scale up, despite
numerous calls to scale up [36].
Therefore, qualitative research is very strongly recom-
mended to determine in which conditions m-Health
works, and if not, why. A process evaluation of the inter-
ventions is highly also recommended. Regarding the
evaluation of impact, a more scientifically sound research
design with a standard definition of adherence, clear spe-
cification of sample, and sample size, appropriate tools, ef-
fective outcome measures on health and health behaviour
are recommended. In health behavioural research, testing
of psychological concepts is also recommended.
As there was no cost data generated in the articles
reviewed, the researchers can not make any meaningful
statement about the cost-benefit aspects of the interven-
tions. The evaluations of m-Health interventions mainly
focused on feasibility, rather than impact and cost-
effectiveness, which makes it difficult to draw conclu-
sions about benefits and, in particular, additional benefits
when compared to traditional interventions.
Limited funding opportunities for long-term interven-
tions and scope of scale up at large scale threaten the
sustainability of the m-Health projects at moment [37].
Most m-Health interventions considered successful in
LMICs, are implemented and/or funded by the non-
governmental organisations (NGOs) and not integrated
into the mainstream national level public health services
[27]. Therefore, more development in the area of cost-
benefit analysis research, together with the sustainability
issue associated with m-Health, is required and recom-
mended before drawing a concrete conclusion on its
economic effect, in order to suggest policy advice for
further decision and implementation.
Conclusion
There is always a positive impact on adherence of dis-
ease management, as well as in health outcomes in al-
most all reviewed articles. But the variability in the type
of intervention (tools and the use of tools) as well as in
the lack of information in most of the articles about the
details of the process of intervention and the concept of
behavioural change, makes the conclusion difficult. Add-
itionally, the methods used to measure the impact, as
well as of the design, sample, and outcome measured
(adherence measured and clinical outcomes), are also
different. Moreover, the low amount of literature pub-
lished on the topic also reduces the power of conclusion.
However, the cost-effectiveness and sustainability issues
of m-Health are still in question, especially in LMICs.
But there is potential in implementing m-Health with
the advancement of new technologies and a wide range
of mobile network coverage; thereby offering the poten-
tial to cover the population who need long term treat-
ment due to chronic diseases/conditions, irrespective of
SES, age, and sex, and therefore make m-Health an im-
portant part of health sector.
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